World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
23911
World Ranking
2379
National Ranking
1138

Overview

Thomas S. Griffith is affiliated with the University of Minnesota in the United States. Their research spans several fields with a primary focus on immunology and microbiology, alongside medicine. The scientist's publication record includes 77 works in immunology and microbiology and 76 in medicine, featuring subfields such as immunology, epidemiology, molecular biology, surgery, and endocrinology, diabetes, and metabolism.

The main topics of Griffith's research encompass a range of subjects related to immune system function and disease mechanisms. These include immune response and inflammation, sepsis diagnosis and treatment, immune cell function and interaction, T-cell and B-cell immunology, immunotherapy and immune responses, neuroinflammation and neurodegeneration mechanisms, and adrenal hormones and disorders.

Griffith's frequent co-authors indicate ongoing collaborative work with other researchers. These include Vladimir P. Badovinac with 50 joint publications, Tamara A. Kucaba (22 publications), Isaac J. Jensen (17 publications), Patrick W. McGonagill (15 publications), and Whitney Swanson (12 publications).

The scientist regularly publishes in several prominent venues. The most frequent publication venues are The Journal of Immunology (20 publications), Frontiers in Immunology (5 publications), ImmunoHorizons (4 publications), bioRxiv (Cold Spring Harbor Laboratory) (4 publications), and Shock (3 publications).

Recent papers by Thomas S. Griffith reflect their focus areas and include:

  • Journal of Pharmacology and Experimental Therapeutics (2024)
  • CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State, Frontiers in Immunology (2020)
  • New Insights into the Immune System Using Dirty Mice, The Journal of Immunology (2020)
  • Immunotherapy for Bladder Cancer: Latest Advances and Ongoing Clinical Trials, Immunological Investigations (2022)
  • Inducing Experimental Polymicrobial Sepsis by Cecal Ligation and Puncture, Current Protocols in Immunology (2020)

Best Publications

  • Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo

    Henning Walczak;Robert E. Miller;Kiley Ariail;Brian Gliniak

  • Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

    Thomas S. Griffith;Thomas Brunner;Sharon M. Fletcher;Douglas R. Green

  • Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells

    Thomas S. Griffith;Wilson A. Chin;Glenn C. Jackson;David H. Lynch

  • CD4 + T-cell help controls CD8 + T-cell memory via TRAIL-mediated activation-induced cell death

    Edith M. Janssen;Nathalie M. Droin;Edward E. Lemmens;Michael J. Pinkoski

  • Intravascular staining for discrimination of vascular and tissue leukocytes

    Kristin G. Anderson;Katrin Mayer-Barber;Heungsup Sung;Lalit K Beura

  • Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

    Ziming Wang;Ethan G. Aguilar;Jesus I. Luna;Cordelia Dunai

  • TRAIL: a molecule with multiple receptors and control mechanisms

    Thomas S Griffith;David H Lynch

  • MONOCYTE-MEDIATED TUMORICIDAL ACTIVITY VIA THE TUMOR NECROSIS FACTOR-RELATED CYTOKINE, TRAIL

    Thomas S. Griffith;Steven R. Wiley;Marek Z. Kubin;Lisa M. Sedger

  • Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

    Neil A. Fanger;Charles R. Maliszewski;Ken Schooley;Thomas S. Griffith

  • CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.

    P M Stuart;T S Griffith;N Usui;J Pepose

  • CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance

    Thomas S Griffith;Xinhong Yu;John M Herndon;Douglas R Green

  • Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand

    Moneeb Ehtesham;Peter Kabos;Mervin A. R. Gutierrez;Nancy H. C. Chung

  • The role of FasL-induced apoptosis in immune privilege

    Thomas S. Griffith;Thomas A. Ferguson

  • Functional Analysis of TRAIL Receptors Using Monoclonal Antibodies

    Thomas S. Griffith;Charles T. Rauch;Pam J. Smolak;Jennifer Y. Waugh

  • Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis

    Yakun Gao;John M. Herndon;Hui Zhang;Thomas S. Griffith

  • Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

    Aaron T. Ludwig;Jill M. Moore;Yi Luo;Xiaohong Chen

  • Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis

    Thomas S. Griffith;Richard D. Anderson;Beverly L. Davidson;Richard D. Williams

  • CD8 T cells utilize TRAIL to control influenza virus infection

    Erik L. Brincks;Arna Katewa;Tamara A. Kucaba;Thomas S. Griffith

  • TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.

    Peter A. Holoch;Thomas S. Griffith

  • Uptake of Apoptotic Antigen-Coupled Cells by Lymphoid Dendritic Cells and Cross-Priming of CD8+ T Cells Produce Active Immune Unresponsiveness

    Thomas A. Ferguson;John Herndon;Bennett Elzey;Thomas S. Griffith

Frequent Co-Authors

Thomas A. Ferguson
Thomas A. Ferguson Washington University in St. Louis
Vladimir P. Badovinac
Vladimir P. Badovinac University of Iowa
Timothy L. Ratliff
Timothy L. Ratliff Purdue University West Lafayette
William M. Nauseef
William M. Nauseef University of Iowa
David M. Ferguson
David M. Ferguson University of Minnesota
Douglas R. Green
Douglas R. Green St. Jude Children's Research Hospital
Surya K. Mallapragada
Surya K. Mallapragada Iowa State University
John T. Harty
John T. Harty University of Iowa
David H. Lynch
David H. Lynch ApoVax, Inc.
Badrinath R. Konety
Badrinath R. Konety University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often overlaps with healthcare fields such as nursing and specialized practitioner roles. Many professionals opt to enhance their qualifications through online programs designed for flexibility and affordability. For those interested in mental health, exploring the cheapest online pmhnp certificate programs can be a cost-effective way to advance clinical skills in psychiatric nursing.

For nurse practitioners aiming to expand their expertise, understanding the financial implications of various specialties is crucial. The dnp salary by specialty resource offers valuable insights into earning potential, helping guide career decisions.

Transitioning between specialties is also a common pathway. For example, nurses looking to move from family practice to more acute care roles can benefit from learning how to make this shift efficiently. The guide on fnp to acute care np offers practical advice for this transition.

Additionally, accelerated programs provide a fast track to becoming a nurse practitioner. Students seeking speed and flexibility might explore the accelerated np programs online, which allow them to earn credentials without prolonged breaks in their professional journey.

By leveraging these pathways and resources, individuals interested in Immunology and related healthcare fields can find tailored programs that fit their career goals and lifestyles.

Best Scientists Citing Thomas S. Griffith

Trending Scientists